References
- Anna Hsu, Carmen P Wong, Zhen Yu, et al (2011) Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics, 3, 3. https://doi.org/10.1186/1868-7083-3-3
- Chomczynski P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156-9.
- Evron E, Umbricht CB, Korz D, et al (2001). Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res, 61, 2782-7.
- Fackler MJ, McVeigh M, Evron E, et al (2003). DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer, 107, 970-5. https://doi.org/10.1002/ijc.11508
- Li S, Rong M, Iacopetta B (2006). DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett, 237, 272-80. https://doi.org/10.1016/j.canlet.2005.06.011
- Padar A, Sathyanarayana UG, Suzuki M, et al (2003). Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. Clin Cancer Res, 9, 4730-4.
- Pongtheerat T, Pakdeethai S, Purisa W, Chariyalertsak S, Petmitr S (2011). Promoter methylation and genetic polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai breast- cancer patients. Asian Pac J Cancer Prev, 12, 2731-4.
- Prowell TM, Fackler M, Argani P, et al (2008). A prospective study of adjuvant anastrozole and gene promoter methylation in the contralateral breast of high-risk women. J Clin Oncol, 26, 1514.
- Ramezani F, Salami S, Omrani MD, Maleki D (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7. https://doi.org/10.7314/APJCP.2012.13.2.451
- Truong PK, Lao TD, Doan TPT, Le TAH (2014). BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population. Asian Pac J Cancer Prev, 15, 9601-10.
- Uhm TG, Lee SK, Kim BS, et al (2012). CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription. Exp Mol Med, 44, 268-80 https://doi.org/10.3858/emm.2012.44.4.022
- Virmani A, Rathi A, Heda S, et al (2003). Aberrant methylation of the cyclin D2 promoter in primary small cell, non-small cell lung and breast cancers. Int J Cancer, 107, 341-5. https://doi.org/10.1002/ijc.11393
- Yu J, Leung WK, Ebert MP, et al (2003). Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. Br J Cancer, 88, 1560-5. https://doi.org/10.1038/sj.bjc.6600940
- Zhang P (1999). The cell cycle and development: redundant roles of cell cycle regulators. Curr Opin Cell Biol, 11, 655-62 https://doi.org/10.1016/S0955-0674(99)00032-0
- Zhu WG, Dai Z, Ding H, et al (2001). Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene, 20, 7787-96. https://doi.org/10.1038/sj.onc.1204970